RYAN ARTHUR F sold REGN

April 1, 2026 · Form 4 insider transaction

RYAN ARTHUR F sold 1 shares of Regeneron Pharmaceuticals, Inc. at $771.32 per share, a transaction worth $771.32. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.

Direction
Disposed (sell-side)
Shares
1
Price
$771.32
Total value
$771.32
Role
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateApril 1, 2026
Filing dateApril 3, 2026
Shares owned after17,702
OwnershipDirect
10b5-1 planYes
AmendedNo

Footnotes

Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c) adopted on October 31, 2025.

View the original Form 4 on SEC EDGAR